MIR4745: A Drug Target / Disease Biomarker (G100616459)
MIR4745: A Drug Target / Disease Biomarker
MIR4745, also known as interleukin-4745, is a protein that is expressed in various tissues throughout the body. It is a member of the interleukin-4 family, which includes other proteins such as IL-1, IL-2, and IL-3. These proteins are involved in the regulation of immune and inflammatory responses. MIR4745 is unique in that it is a sphingomyelin-rich protein, which means that it is covered in a layer of sphingomyelin, a type of lipid molecule.
One of the things that makes MIR4745 so interesting as a drug target is its unique structure. MIR4745 has a unique shape, with a long tail that is involved in its function. This tail is able to interact with other proteins, which allows it to play a role in the development and progression of various diseases.
In addition to its unique structure, MIR4745 is also notable for its role in the regulation of inflammation. It has been shown to play a role in the regulation of immune responses and has been linked to the development of various inflammatory diseases. This makes it an attractive target for researchers looking for new treatments for these diseases.
Another potential use for MIR4745 is its role in the regulation of cell growth. It has been shown to play a role in the regulation of cell growth and has been linked to the development of various cancerous tumors. This makes it an important target for researchers studying the causes and progression of cancer.
MIR4745 is also of interest to researchers because of its ability to be targeted with small molecules. This makes it an attractive target for drug development because it can be easily modified and tested for effectiveness.
In conclusion, MIR4745 is a protein that is of interest to researchers because of its unique structure and its role in the regulation of immune and inflammatory responses, as well as its role in cell growth and cancer development. As a drug target, MIR4745 has the potential to be a valuable new treatment for a variety of diseases.
Protein Name: MicroRNA 4745
The "MIR4745 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4745 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505
